Weill Cornell GI Oncology Program

Home
United States
New York, NY
Weill Cornell GI Oncology Program

Enabling patients across the entire spectrum of cancers of the digestive system to have the highest quality care and treatment.

As New York’s premier healthcare network, Weill Cornell Medicine is at the forefront of scientific research and clinical trials. The Gastrointestinal (GI) Oncology Program provides access to state-of-the-art treatments, offering patients the opportunity to receive treatments not available elsewhere. Our physicians, ranging from our medical oncologists, world-class surgical oncologists, gastroenterologists and radiation oncologists, use the approach of precision medicine, which provides individualized cancer treatment based on specific genetic vulnerabilities of each patient’s tumor. Gastrointestinal cancers include:

• Esophagus and gastro-esophageal cancers
• Pancreatic cancers
• Stomach (Gastric) cancers
• Colon cancers
• Re**al and a**l cancers
• Liver cancers
• Neuroendocrine cancers
• Gallbladder cancers
• Cancers of the small intestine
• Sarcomas, including GIST

Our page aims to provide you with the latest information and research developments.

12/23/2025

Dr. Rutika Mehta moderated a program to discuss results from a phase 3 evaluating a combination treatment regimen recently approved by the U.S. Food and Drug Administration for :

A panel of experts gathered to discuss results from the MATTERHORN trial assessing durvalumab plus FLOT in gastric/GEJ cancer.

12/11/2025

Watch Dr. Despina Siolas provide insights into the important we’re doing Weill Cornell Medicine to find ways to personalize treatment:

Dr. Despina Siolas, assistant professor of medicine at Weill Cornell Medicine, is working to personalize treatment for pancreatic cancer and develop new therapeutic regimens that save more patient lives.

10/29/2025

WATCH: Dr. Rutika Mehta discusses targeted approaches to biomarker testing for patients with upper gastrointestinal ( ) malignancies:

Rutika Mehta, MD, MPH, discusses targeted approaches to biomarker testing for patients with upper gastrointestinal malignancies.

09/23/2025

Dr. Despina Siolas spoke with Women's Health about potential symptoms that shouldn’t be ignored as part of an article on when to see a doctor for health concerns:

Beyond the expected ones.

04/10/2025

Join us in our social media welcome for GI medical oncologist Dr. Rutika Mehta! Dr. Mehta is available for appointments for patients with all types of : https://bit.ly/42WsKkm

03/25/2024

Dr. Manish Shah breaks down everything patients should know about , including common symptoms, arriving at a diagnosis, and the latest treatments. Read more via NewYork-Presbyterian Hospital:

A medical oncologist explains the symptoms of stomach cancer, how it’s diagnosed, and the latest treatments.

03/21/2024

A recent study led by Dr. Pashtoon Kasi evaluating two next-generation drugs shows promising activity against Stage IV when there are no tumors in the liver:

Giving two immunotherapy drugs before surgery to remove colorectal cancer shows highly promising results

10/02/2023

led by Dr. Pashtoon Kasi showed that giving early-stage patients an investigational prior to surgery could have promising results: https://bit.ly/3ZQRKWR (cc: Forbes)

A combination immunotherapy developed by biotech company Agenus administered before surgery destroyed over 80% of a tumor before it was removed.

06/23/2023

05/19/2023

Dr. Manish Shah spoke with Medpage Today about the new ASCO guidelines on advanced . He was also part of the expert panel that developed these guidelines:

Recommendations for use of immunotherapy and targeted therapy

05/17/2023

“There is a clear high, ongoing unmet medical need for patients with advanced gastric and G-junction adenocarcinoma,” said Dr. Manish Shah re: combining zolbetuximab + chemo for a subset of gastric or gastroesophageal junction patients:

An abstract is unavailable.

05/15/2023

Dr. Felice Schnoll-Sussman of Weill Cornell Medicine/NewYork-Presbyterian Hospital Gastroenterology shares facts, risk factors, and screening information about :

Former TV show host Jerry Springer, 79, has died of pancreatic cancer after a "brief illness," his family and publicist confirmed last week. A short illness timeline is common among pancreatic cancer patients, since the disease is often diagnosed in later stages and is very difficult to treat.

Address

1305 York Avenue
New York, NY
10021

Telephone

(646) 962-6200

Website

https://weillcornell.org/gicancer

Alerts

Be the first to know and let us send you an email when Weill Cornell GI Oncology Program posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Magnus Wellness
16 E 40th Street, Fl 4

Want your practice to be the top-listed Clinic in New York?

Our Story

The Gastrointestinal (GI) Oncology Program at Weill Cornell Medicine and NewYork-Presbyterian is dedicated to providing state-of-the-art personalized care across the entire spectrum of cancers of the digestive system.

Our team works relentlessly to improve the lives of people with gastrointestinal cancer. We pride ourselves on putting patients first, tailoring treatment to each individual’s unique needs in order to maximize health outcomes and minimize potential side effects of therapy.